[HTML][HTML] SARS-CoV-2–related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
Multisystem inflammatory syndrome in children (MIS-C) emerged in April 2020 in
communities with high COVID-19 rates. This new condition is heterogenous but resembles …
communities with high COVID-19 rates. This new condition is heterogenous but resembles …
COVID-19 pandemic as risk factors for excessive weight gain in pediatrics: the role of changes in nutrition behavior. A narrative review
H Cena, L Fiechtner, A Vincenti, VC Magenes… - Nutrients, 2021 - mdpi.com
During the coronavirus disease 2019 (COVID-19) pandemic, social isolation, semi-
lockdown, and “stay at home” orders were imposed upon the population in the interest of …
lockdown, and “stay at home” orders were imposed upon the population in the interest of …
Longitudinal outcomes for multisystem inflammatory syndrome in children
BACKGROUND In spring 2020, a novel hyperinflammatory process associated with severe
acute respiratory syndrome coronavirus 2 multisystem inflammatory syndrome in children …
acute respiratory syndrome coronavirus 2 multisystem inflammatory syndrome in children …
Multisystem inflammatory syndrome in children (MIS-C)
JM Patel - Current allergy and asthma reports, 2022 - Springer
Abstract Purpose of Review The novel coronavirus disease 2019 (COVID-19) is caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has developed into a …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has developed into a …
Best practice recommendations for the diagnosis and management of children with pediatric inflammatory multisystem syndrome temporally associated with SARS …
LJ Schlapbach, MC Andre, S Grazioli, N Schöbi… - Frontiers in …, 2021 - frontiersin.org
Background: Following the spread of the coronavirus disease 2019 (COVID-19) pandemic a
new disease entity emerged, defined as Pediatric Inflammatory Multisystem Syndrome …
new disease entity emerged, defined as Pediatric Inflammatory Multisystem Syndrome …
Understanding COVID-19 in children: immune determinants and post-infection conditions
Coronavirus disease 2019 in children presents with milder clinical manifestations than in
adults. On the other hand, the presence of a wide range of inflammatory manifestations …
adults. On the other hand, the presence of a wide range of inflammatory manifestations …
Current understanding of multisystem inflammatory syndrome (MIS-C) following COVID-19 and its distinction from Kawasaki disease
H Bukulmez - Current rheumatology reports, 2021 - Springer
Abstract Purpose of Review In this article, I have reviewed current reports that explore
differences and similarities between multisystem inflammatory syndrome in children (MIS-C) …
differences and similarities between multisystem inflammatory syndrome in children (MIS-C) …
Multisystem inflammatory syndrome in children with COVID-19
M Gottlieb, R Bridwell, J Ravera, B Long - The American Journal of …, 2021 - Elsevier
Background Multisystem inflammatory syndrome in children (MIS-C) is a dangerous
pediatric complication of COVID-19. Objective The purpose of this review article is to provide …
pediatric complication of COVID-19. Objective The purpose of this review article is to provide …
Long-term physical, mental and social health effects of COVID-19 in the pediatric population: A scoping review
M Borel, L Xie, O Kapera, A Mihalcea, J Kahn… - World Journal of …, 2022 - Springer
Background The majority of coronavirus disease 2019 (COVID-19) symptom presentations
in adults and children appear to run their course within a couple of weeks. However, a …
in adults and children appear to run their course within a couple of weeks. However, a …
Pathogenesis, immunology, and immune‐targeted management of the multisystem inflammatory syndrome in children (MIS‐C) or pediatric inflammatory multisystem …
W Feleszko, M Okarska‐Napierała… - Pediatric Allergy and …, 2023 - Wiley Online Library
Multisystem inflammatory syndrome in children (MIS‐C) is a rare, but severe complication of
coronavirus disease 2019 (COVID‐19). It develops approximately 4 weeks after severe …
coronavirus disease 2019 (COVID‐19). It develops approximately 4 weeks after severe …